Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the latest arisen contagious respiratory pathogen related to the global outbreak of atypical pneumonia pandemic (COVID-19). The essential oils (EOs) of Eucalyptus camaldulensis, E. ficifolia F. Muell., E. citriodora Hook, E. globulus Labill, E. sideroxylon Cunn. ex Woolls, and E. torquata Luehm. were investigated for its antiviral activity against SARS-CoV-2. The EOs phytochemical composition was determined using GC/MS analysis. Correlation with the explored antiviral activity was also studied using multi-variate data analysis and Pearson’s correlation. The antiviral MTT and cytopathic effect inhibition assays revealed very potent and promising anti SARS-CoV-2 potential for E. citriodora EO (IC50 = 0.00019 µg/mL and SI = 26.27). The multivariate analysis revealed α-pinene, α-terpinyl acetate, globulol, γ -terpinene, and pinocarvone were the main biomarkers for E. citriodora oil. Pearson’s correlation revealed that globulol is the top positively correlated compound in E. citriodora oil to its newly explored potent anti SARS-CoV-2 potential. A molecular simulation was performed on globulol via docking in the main active sites of both SARS-CoV-2 viral main protease (Mpro) and spike protein (S). In silico predictive ADMET study was also developed to investigate the pharmacokinetic profile and predict globulol toxicity. The obtained in silico, in vitro and Pearson’s correlation results were aligned showing promising SARS-CoV-2 inhibitory activity of E. citriodora and globulol. This study is a first record for E. citriodora EO as a novel lead exhibiting potent in vitro, and in silico anti SARS-CoV-2 potential and suggesting its component globulol as a promising candidate for further extensive in silico, in vitro and in vivo anti-COVID studies.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Essential oils (EOs) have a numerous biological activities; anti-parkinson, antifungal, anticarcinogenic, insecticide, anti-inflammatory, antimicrobial, antiviral and antioxidant [1, 2].The interest in EOs has been growing in food, cosmetic, medical, and pharmaceutical fields [3].
EOs and their pure compounds have been expressed as valuable antiviral drug candidates against RNA and DNA viruses in various host cell lines by blocking different steps of the viral life cycle [4]. These effects are due to the oil mono- and sesquiterpene hydrocarbons, alcoholic, phenolic, and other oxygenated constituents [4]. They have been documented against a variety of viruses; avian influenza A virus, human herpes virus, human immunodeficiency virus, Zika virus, and influenza A virus (H1N1) [5].
In this context, the biological activity of EOs could be extremely useful for management of the COVID-19 pandemic. Recently many plants EOs have been reported to exhibit a significant antiviral potential against SARS-CoV-2. Allium sativum, Melissa officinalis, Citrus limon, Eugenia brasiliensis, Cedrus libani, Geranium dissectum, Zataria multiflora, Zingiber zerumbet and, Vetiveria zizanoides. EOs together with their derivative compounds have been suggested as potent anti-COVID drugs, which could hinder CoV entry into the human body [6, 7].
The symptoms of SARS-CoV-2 have an incubation period of 2 weeks until the signs; cough, fever, lung damage, and dyspnea are expressed [8]. While studying drug targeting for the optimization of novel SARS-CoV-2 inhibitors, it was noted that the main protease (Mpro), as an ideal target for drug development, is responsible for major vital functions including the viral replication processes, with a highly conserved catalytic domain. Also, angiotensin-converting enzyme-2 (ACE2) receptor showed a crucial role in infection through a receptor-mediated interaction. Where a great similarity between SARS-CoV-2 and SARS virus was computationally proved, with the highest affinity to receptor ACE2 as a first binding step at the cell membrane. Followed by SARS-CoV-2 entry being mediated by spike glycoprotein. This allows the virus entry into the host cell through the active receptor-binding domain (RBD) in the spike protein (S) found on surface of the virus [9]. Recently it was documented that the blocking ACE2 and the (S) is one possible way of inhibiting the entrance of SARS-CoV-2 to the host cell. Thus, drugs that can inhibit one of these proteins would be identified as potential new anti-COVID compounds [9, 10].
Eucalyptus is a well-known genus belongs to family Myrtaceae. It is traditionally used to treat many disorders [11]. The Eucalyptus genus is characterized by 900 species and subspecies which is native to Australia and cultivated worldwide. This plants contains wide array of phytochemicals as essential oils, phloroglucinols, tannins, flavonoids, oleuropeic acid derivatives and triterpenes [12]. Eucalyptus possesses antiviral, antibacterial, anticancer, antioxidant, antiseptic, antigout and anti-inflammatory potentials [11, 13].
In a continuation of our previous study for exploring anti SARS-CoV-2 drugs [14] and our previous research on Eucalyptus antiviral potential [12], Eucalyptus EOs were selected for this study. Eucalyptus trees have perennial leaves that are odorous due to the presence of EOs, produced and stored in secretory cells. These EOs are aromatic, spicy, and colorless or pale yellow, or brownish or greenish in color [15]. Eucalyptus EOs are rich in monoterpenes and sometimes in sesquiterpenes. They are rich in 1,8-cineole, citral, citronellal and geranyl acetate [16]. Eucalyptus EOs exhibit potent antimicrobial, acaricidal, insecticidal, anticancer, and herbicidal properties. Their pharmaceutical industrial, and agrochemical applications in addition to food preservation properties are well documented [17].
There are few data about the potential of Eucalyptus EOs and its components against the COVID-19 virus. The present study aimed at evaluating the in vitro anti SARS-CoV-2 potential of six Eucalyptus species; Eucalyptus camaldulensis Dehnh, E. ficifolia F.Muell., E. citriodora Hook, E. globulus Labill, E. torquata Luehm., and E. sideroxylon Cunn. ex Woolls, and to correlate the observed in vitro activity if any with the phytochemical components of oils in an attempt to explore novel lead for management of COVID infection.
Materials and Methods
The detailed procedures are described in the supplementary online resource.
Results and Discussion
The current crisis caused by SARS-CoV-2 reveals the need for new potent antiviral drugs. Recent studies focused on exploring new compounds from medicinal plants EOs as a promising sources exhibiting potential against virus infection and replication [18]. The antiviral activities of EOs against SARS-CoV-2 using several approaches such as in vitro, docking models or in clinical instances were previously investigated [19].
EOs lipophilic structure allows them to invade the virus envelope then, modulates the viral lipid double layer fluidity permitting the disturbance its life cycle [20]. EOs different antiviral mechanisms have been studied. Some exhibited their activity through immediate effects on free viruses, blocking of different virus life cycle steps for examples as fusion, replication and release from host cells, and inhibition of the key viral enzymes [5]. Some EO components were reported to diminish viral infectivity by more than 80% [21].
Eucalyptus EOs and some of their components were reported before for their antiviral properties against many viruses [21,22,23,24], but they were not tested before against the COVID-19 virus.
Anti-SARS-CoV-2
The results were determined by calculating the CC50 in addition to the IC50 that is required to reduce the virus-induced cytopathic effect (CPE) by 50% (Fig. S1). The overall therapeutic activity of the active one was established in terms of the SI (the ratio of the CC50 to IC50). The most promising one is E. citriodora with IC50 = 0.00019 µg/mL from the tested samples against SARS-CoV-2. High SI values (more than 10) recommend the drug is a good candidate as antiviral agent and that its effect is more directed toward the viral inhibition with less cytotoxic activity on the host cell [25]. This revealed a promising activity for E. citriodora leaves EO against SARS-CoV-2 with a significant SI (26.27 × 1000). E. torquata had high cytotoxicity effect on cells and so no further biological evaluation was carried out on E. torquata EO.
GC/MS Analysis
The hydro distilled EOs obtained from six Eucalyptus species offered a range yield of 0.7–2.3% v/w. A total of 53 components, comprising 92.1-97.96% of the total composition of the different samples, were identified and quantified using GC-MS analysis. The chemical names and the area % of identified constituents are tabulated in Table S1. The results revealed that monoterpenes are the principal components of the tested oils, with a good percentage of sesquiterpenes constituents. Oxygenated monoterpenes are the most abundant phytoconstituents of E. ficifolia and E. sideroxylon oils amounted to 37.70% and59.41% of the identified compounds. On the other hand, the monoterpene hydrocarbon is the most abundant group in E. citriodora (64.2%) and E. globulus (39.8%) oils. E. camaldulensis (41.6%) and E. torquata (45.68%) oils are the richest oils in oxygenated sesquiterpenes (Table S1).
In this study, E. citriodora showed very promising anti SARS-CoV-2 potential. GC/MS of the EOs from six Eucalyptus leaves showed variation in their essential constituents. Monoterpenes, oxygenated monoterpenes, and sesquiterpenes were the major class of essential constituents. Many of the GC-MS detected components of the EOs under investigation are previously reported to exhibit antiviral activity. β-pinene, α-pinene, γ-terpinene, 1,8-cineole and terpinen-4-ol revealed anti-herpes simplex virus type 1 activity more than 80% [21]. α-terpinyl acetate was reported to play a key role in inhibiting replication of SARS-CoV-2 via binding to Nsp15 viral protein and they might [26]. Eucalyptol (1,8 cineole) was previously reported as a promising therapeutic agent in the management of COVID-19 [27]. It was well documented that α-pinene not only exerted potent antiviral activity against HSV-1 [28] but also both α and β-pinene were reported to inhibit the binding between RNA and the IBV N-protein, consequently, possess anti-IBV activity [29]. Furthermore, in silico studies highlighted their ability of binding to the active site of human serine protease TMPRSS2, Mpro, and spike (S) glycoprotein leading to their anti-SARS-CoV-2 potential [4, 28]. α and β-Pinene were reported in several recent in silico studies to exhibit anti-COVID potential [18]. Also, borneol exhibited a potent antiviral activity against orthopoxvirus and influenza A virus [30].
Multivariate Data Analysis and Pearson’s Correlation
Although some differences in the six species phytochemical pattern were noticed by simple visual inspection of GC/MS results (Table S1), MVDA including hierarchical cluster analysis (HCA) and principal component analysis (PCA) were used to evaluate the chemical diversity and explore the relative variability within the oils GC-MS derived dataset in a more holistic way. PCA revealed that the six species were divided into 3 main clusters: the first cluster representing E. citriodora oil only, the second cluster representing E. camaldulensis, E. ficifolia, and E. globulus oils, the third cluster including E. sideroxylon and E. torquata oils (Fig. S2A). This confirms that E. citriodora oil was different in the levels and occurrence of certain phytochemicals and discriminated from the other five Eucalyptus species. Two principal components cumulatively accounted for 56.97% of the total variance (Fig. S2A). PCA revealed that PC1 and PC2 explained 21.94% and 35.03% of the variance respectively.
The PCA of the main discriminatory markers of each cluster (Fig. S2B) revealed that α-pinene, α-terpinyl acetate, globulol, γ-terpinene, borneol, β-pinene, epiglobulol, γ-terpinyl acetate, fenchol, campholenal, piperitone, citronellyl acetate, trans-carveol, and pinocarvone were the main biomarkers for E. citriodora oil while linalool, m-cumenol, and terinen-4-ol are the main discriminatory biomarkers for the second cluster E. camaldulensis, E. ficifolia, and E. globulus oils.
The dendrogram (Fig. S3) of the six Eucalyptus species were grouped according to their chemical profiles into four clusters (clusters I-IV). The first cluster (cluster I) was composed of E. citriodora oil only which was more diverged among all tested species. The second cluster (cluster II) comprised E. camaldulensis oil. The third and fourth clusters comprised; cluster III: E. sideroxylon and E. torquata oils and cluster IV: E. ficifolia, and E. globulus oils, suggesting that they have comparable phytochemical profiles.
Quantitative heatmap (Fig. S3) was constructed to visualize and assess qualitative and quantitative differences across the tested eucalyptus oils. The heatmap revealed the main clusters of phytochemicals of highest abundance in each of the six studied Eucalyptus species. From the color code (Fig. S3) compounds with red colors are those of the highest abundance. α-pinene, α-terpinyl acetate, (-)-globulol, γ-terpinene, borneol (2.48%), β-pinene, epiglobulol, γ-terpinyl acetate, fenchol (0.83%), campholenal (0.44%), piperitone, citronellyl acetate, trans-carveol, pinocarvone are of highest abundance in E. citriodora oil relative to other eucalyptus oils. On the other hand, α-ylangene, cis sabinene hydrate, spathulenol, cis thujopsene, isospanthlenol, α-cadinol, β-myrecene, Selina 5, 11 diene, delta 2 carene, isothujyl acetate were the main phytoconstituents discriminating E. camaldulensis oil. E. sideroxylon oil was distinguished by the relative high abundance of α- phellandrene, trans thujopsene, 1,8- cineole, and viridiflorol. α-Thujene, trans-sabinol, γ-eudesmol, and torquatone were detected as the majors phytoconstituents discriminating E. torquata oil. Trans nerolidol, p cymene7ol, citronellal, isoborneol were of highest relative abundance in E. ficifolia oil. Finally, cis sabinene hydrate acetate, carvacrol, and estragol are the characteristic components of E. globulus oil.
Although some differences in the six species essential oil chemical pattern were observed by simple visual inspection of the PCA (Fig. S2), and the heatmap (Fig. S3) applied on the identified compounds in each tested oil, it was crucial to apply Pearson’s linear correlation to explore whether certain essential oil component is significantly correlated with the very potent newly observed E. citridora oil anti-SARS-CoV-2 potential or this potent activity was due to the synergistic activity of many components at the same time. Hence, E. torquata oil had high cytotoxic effect, the GC/MS results of this oil were not included in Pearson’s correlation.
Pearson’s linear correlation results revealed that globulol was the top positively correlated compound in the E. citriodora oil (Fig. S4A). Chemometric study was performed based on GC data where PCA revealed the biomarkers of each EO sample and discriminated them into separated clusters. Globulol is an antimicrobial sesquiterpene alcohol previously isolated from the fruits of E. globulus Labill (Myrtaceae) [31]. It has also been reported to have potent antioxidant and antifungal activities [32]. On the other hand, carvacrol, estragole, cis-sabinene hydrate acetate, trans-p-menth-1-en-3-ol, α-thujene, β-cymene, trans-sabinene hydrate, m-cumenol, cryptone, cuminaldehyde, and β-phellandrene were negatively correlated to the observed E. citriodora oil. Structures of the top ten positively correlated compounds were illustrated in Fig. S4B. Hence the correlation coefficient of globulol is 0.5 and since many components of E. citriodora oil α-pinene, β-pinene, α-terpinyl acetate, and 1,8 cineol (eucalyptol) are of well documented anti-viral and anti-COVID potential [18, 28, 29, 33], it was concluded that this very potent anti-COVID activity exhibited by E. citriodora oil was due to strong synergistic activity of several compounds with each other. In other words, the presence of α-pinene, β-pinene, α-terpinyl acetate, 1,8 cineol, globulol with each other was responsible for the activity and not to globulol only.
Molecular Modeling
An in-silico docking study applying C-Docker protocol using Discovery Studio 4.0 Software on globulol was performed. After preparing the tested ligand, docking into each of the two binding sites of Mpro and S receptors was achieved using C-Docker protocol. The analysis study was further applied to distinguish the binding mode of globulol and to interpret the estimated biological results. The best pose of globulol showing comparable binding mode (with the key amino acids in the binding site) to the complexed ligand was selected. Also, validation was confirmed by re-docking of the complexed ligands in the specific active site of each of the two targets showing RMSD value = 0.5 A° as good validation results.
The main reported binding interaction at the active sites from the previous literature and the docking results of the ligand as well were used to evaluate the docking results of globulol. C-Docker results on Mpro active site (E=-26.19 Kcal/mol) in Fig. S5, showed that it retained the essential hydrogen bond interaction with GLU166 as in boceprevir ligand (E=-71.5 Kcal/mol). Besides the other reported hydrophobic interactions with HIS41, MET49 and MET165. Also, an interaction with CYS145 was recorded but with hydrophobic binding not hydrogen bond compared to ligand [34].
While docking results of globulol on spike (S) receptor was compared to NAG docking results besides the previously published essential interactions at the binding site [34]. It was observed that NAG (E=-24.12 Kcal/mol) showed one hydrogen bond HBD with GLY339 residue, this was replaced by two hydrogen bonds (1HBD and 1HBA) with ASN343 residue by globulol (E=-18.04 Kcal/mol) (Fig. S6), that was thought to enhance the binding affinity of globulol [34]. Besides, the hydrophobic interactions with PHE342 and LEU368 residues.
It’s worth noting that the glycosylated nature of spike proteins in Coronavirus with N-acetyl glucosamine (NAG) as the main component, influenced its structural packaging. And removal of glycosylation will not only distort but also affect its structure for proper binding [35].
Results of globulol docking on the two mentioned active sites showed promising estimated activity of the test compound as COVID-19 treatment candidate with good interaction with the essential amino acids in the binding sites (Fig. S7).
Also, an ADMET study was conducted to evaluate the pharmacokinetic profile of globulol using Discovery Studio 4.0 Software. The aim of the study was to investigate the drug-likeness of the compound based on correlating the chemical structure to several calculated parameters including; Aqueous solubility level, Atom based Log P98 (A LogP 98), Blood Brain Barrier Level, Cytochrome P450 2D6 (CYP2D6), Hepatotoxicity Probability, Absorption level, Plasma protein binding level (PPB Level), 2D polar surface area (ADMET 2D PSA) and toxicity being predicted by Komputer Assisted Technology (TOPKAT) [36].
Table S2 demonstrated the ADMET results showing that globulol exerts BBB level of 1, which indicates moderate BBB penetration. Absorption level value of 0, indicating good level of human intestinal absorption. With low ADME aqueous solubility level of 2. Log P parameter indicates the lipophilicity of the compound, it can be together with the polar surface area (PSA), used for evaluation. Where compounds that do not exceed the value of 5 (3.202 for globulol), are usually considered for their well absorption. On the other hand, the bioavailability is greatly related to the (PSA) property of the drug. As molecules with PSA < 140 (20.815 for globulol) show more passive absorption. Hereby, globulol showed hepatotoxicity probability. It is considered as Cytochrome P450 2D6 (CYP2D6) non inhibitor, with a probability for plasma protein binding. While toxicity prediction (TOPKAT) showed non mutagen result.
The in-silico ADMET prediction study of globulol showed good pharmacokinetic profile as a non CYP450 inhibitor with good intestinal absorption level showing good passive oral absorption and the most important is being a non-mutagen drug regarding toxicity prediction (Fig. S8).
Hence, globulol is the most correlated compound to the anti SARS activity with appropriate binding to the key amino acids, this suggested that E. citriodora oil, and globulol needs extensive in depth detailed in vitro, in silico, and in vivo studies to find out the possibility of their use in management of SARS-CoV-2 infection. Mechanism of antiviral studies on E. citriodora oil and globulol are highly recommended. In addition, EOs chemical composition may vary from one season to another even if extracted from the same plant, which can affect the biological response. Thus, it is highly recommended that further studies on seasonal variations of the studied species EOs composition to be conducted.
Consequently, this study reveals that Eucalyptus EOs have antiviral potential matching with the genus reported folk uses. Furthermore, our study recommended E. citriodora and its component globulol as antiviral agent against the pandemic COVID-19. The use of the EOs as natural antiviral drugs requests further detailed studies to approve their effectiveness and safety.
Conclusion
Together with the approved vaccines, the innovation of prospective anti-COVID-19 drugs has been targeted. Our study revealed E. citriodora EO as a very potent anti SARS-CoV-2 potential. Multivariate analysis revealed α-pinene, α-terpinyl acetate, globulol, γ-terpinene, borneol, β-pinene, along with other components as the main E. citriodora EO biomarkers. Globulol was the top positively correlated compound with this newly explored activity. Molecular modeling revealed that globulol exhibited comparable results to the downloaded ligands at the active sites and confirmed the binding to the key amino acids with appropriate binding energy. This is the sole map representing the chemical profiling of some common and rare Eucalytpus species in correlation with their anti-SARS-CoV-2 potential. E. citriodora oil and globulol may serve as a potential source of plant-based drugs for SARS-CoV-2 control.
Data Availability
No datasets were generated or analysed during the current study.
References
Galvan D, Effting L, Torres Neto L, Conte-Junior CA (2021) An overview of research of essential oils by self‐organizing maps: a novel approach for meta‐analysis study. Compr Rev Food Sci Food Saf 20(4):3136–3163
Telerman A, Ravid U, Dudai N, Elmann A (2023) Therapeutic effects of geranium oil in MPTP-induced Parkinsonian mouse model. Plant Foods Hum Nutr 78(4):768–775
Panikar S, Shoba G, Arun M, Sahayarayan JJ, Nanthini AUR, Chinnathambi A, Alharbi SA, Nasif O, Kim H-J 2021 essential oils as an effective alternative for the treatment of COVID-19: molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties. J Infect Public Health 14(5):601–610
Reichling J (2021) Antiviral and virucidal properties of essential oils and isolated compounds–a scientific approach. Planta Medica 88:587-603
Ma L, Yao L (2020) Antiviral effects of plant-derived essential oils and their components: an updated review. Molecules 25(11):2627
Thuy BTP, My TTA, Hai NTT, Hieu LT, Hoa TT, Thi Phuong H, Loan NT, Triet TTV, Anh PT, Quy, Tat PV 2020 investigation into SARS-CoV-2 resistance of compounds in garlic essential oil. ACS Omega 5(14): 8312–8320
Torres Neto L, Monteiro MLG, Galvan D, Conte-Junior CA (2021) An evaluation of the potential of essential oils against SARS-CoV-2 from in silico studies through the systematic review using a chemometric approach. Pharmaceuticals 14(11):1138
Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, Ganesan S, Venugopal A, Venkatesan D, Ganesan H 2020 COVID-19: a promising cure for the global panic. Sci Total Environ 725: 138277
Gowrishankar S, Muthumanickam S, Kamaladevi A, Karthika C, Jothi R, Boomi P, Maniazhagu D, Pandian SK (2021) Promising phytochemicals of traditional Indian herbal steam inhalation therapy to combat COVID-19–An in silico study. Food Chem Toxicol 148:111966
Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, and Tsiodras (2020) Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infect Genet Evol 79:104212
Ghareeb MA, Sobeh M, El-Maadawy WH, Mohammed HS, Khalil H, Botros S, Wink M (2019) Chemical profiling of polyphenolics in Eucalyptus globulus and evaluation of its hepato–renal protective potential against cyclophosphamide induced toxicity in mice. Antioxidants 8(9):415
Okba MM, El RA, Gedaily, Ashour RM (2017) UPLC–PDA–ESI–qTOF-MS profiling and potent anti-HSV-II activity of Eucalyptus sideroxylon leaves. J Chromatogr B 1068:335–342
Ashour RM, El-Shiekh RA, Sobeh M, Abdelfattah MA, Abdel-Aziz MM, Okba MM (2023) Eucalyptus torquata L. flowers: a comprehensive study reporting their metabolites profiling and anti-gouty arthritis potential. Sci Rep 13(1):18682
El-Shiekh RA, Ashour RM, Okba MM, Mandour AA, Kutkat O, Moatasim Y, Elshimy R (2023) Natural compounds as possible anti–SARS-CoV-2 therapeutic agents: an in-vitro and in-silico study. Nat Prod Res 1–6
Araújo FOL, Rietzler LP, Duarte GDdF, Silva F, Carazza and S.A. Vieira Filho, 2010 Constituintes químicos e efeito ecotoxicológico do óleo volátil de folhas de Eucalyptus urograndis (Mirtaceae). Química Nova. 33:1510–1513
Pino JA, Marbot R, Quert R, García H (2002) Study of essential oils of Eucalyptus resinifera Smith, E. tereticornis Smith and Corymbia maculata (hook.) KD Hill & LAS Johnson, grown in Cuba. Flavour Fragr J 17(1):1–4
Salehi B, Sharifi-Rad J, Quispe C, Llaique H, Villalobos M, Smeriglio A, Trombetta D, Ezzat SM, Salem MA, Zayed A (2019) Insights into Eucalyptus Genus chemical constituents, biological activities and health-promoting effects. Trends Food Sci Technol 91:609–624
Mohamed ME, Tawfeek N, Elbaramawi SS, Fikry E (2022) Agathis robusta bark essential oil effectiveness against COVID-19: chemical composition, in silico and in vitro approaches. Plants 11(5):663
Asif M, Saleem M, Saadullah M, Yaseen HS, Al Zarzour R (2020) COVID-19 and therapy with essential oils having antiviral, anti-inflammatory, and immunomodulatory properties. Inflammopharmacology 28:1153–1161
Wink M 2020 potential of DNA intercalating alkaloids and other plant secondary metabolites against SARS-CoV-2 causing COVID-19. Diversity. 12(5): p. 175
Astani A, Reichling J, Schnitzler P (2010) Comparative study on the antiviral activity of selected monoterpenes derived from essential oils. Phytotherapy Research: An International Journal devoted to pharmacological and toxicological evaluation of natural product derivatives. 24(5):673–679
Schnitzler P, Schön K, Reichling J (2001) Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture. Pharmazie 56(4):343–347
Cermelli C, Fabio A, Fabio G, Quaglio P (2008) Effect of eucalyptus essential oil on respiratory bacteria and viruses. Curr Microbiol 56:89–92
Astani A, Schnitzler P (2014) Antiviral activity of monoterpenes beta-pinene and limonene against herpes simplex virus in vitro. Iran J Microbiol 6(3):149
Indrayanto G, Putra GS, Suhud F (2021) Validation of in-vitro bioassay methods: application in herbal drug research. Profiles Drug Substances Excipients Relat Methodol 46:p273–307
Kumar S, Kashyap P, Chowdhury S, Kumar S, Panwar A, Kumar A (2021) Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication. Phytomedicine 85:153317
Sharma AD (2020) Eucalyptol (1, 8 cineole) from eucalyptus essential oil a potential inhibitor of COVID 19 corona virus infection by molecular docking studies
Mieres-Castro D, Ahmar S, Shabbir R, Mora-Poblete F (2021) Antiviral activities of eucalyptus essential oils: their effectiveness as therapeutic targets against human viruses. Pharmaceuticals 14(12):1210
Yang Z, Wu N, Zu Y, Fu Y (2011) Comparative anti-infectious bronchitis virus (IBV) activity of (-)-pinene: Effect on nucleocapsid (N) protein. Molecules 16(2):1044–1054
Sokolova A, Yarovaya O, Semenova M, Shtro A, Orshanskaya I, Zarubaev V, Salakhutdinov N (2017) Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza a virus. MedChemComm 8(5):960–963
Tan M, Zhou L, Huang Y, Wang Y, Hao X, Wang J (2008) Antimicrobial activity of globulol isolated from the fruits of Eucalyptus globulus Labill. Nat Prod Res 22(7):569–575
Rodriguez S, Sueiro RA, Murray AP, Leiro JM (2019) Bioactive sesquiterpene obtained from Schinus Areira L.(Anacardiaceae) essential oil. Multidisciplinary Digit Publishing Inst Proc 41(1):85
Roviello V, Roviello GN, Less (2021) COVID-19 deaths in southern and insular Italy explained by forest bathing, Mediterranean environment, and antiviral plant volatile organic compounds. Environmental chemistry letters: 1–11
Alesawy MS, Abdallah AE, Taghour MS, Elkaeed EB, Eissa IH, Metwaly AM (2021) Silico studies of some isoflavonoids as potential candidates against COVID-19 targeting human ACE2 (hACE2) and viral main protease (Mpro). Molecules 26(9):2806
Banerjee A, Santra D, Maiti S, Energetics (2020) and IC50 based epitope screening in SARS CoV-2 (COVID 19) spike protein by immunoinformatic analysis implicating for a suitable vaccine development. J Translational Med. 18(1): 1–14
Mandour AA, Nassar IF, Abdel Aal MT, Shahin MA, El-Sayed WA, Hegazy M, Yehia AM, Ismail A, Hagras M, Elkaeed EB (2022) Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo [3, 4-d] pyrimidine and pyrazolo [4, 3-e][1, 2, 4] triazolo [1, 5-c] pyrimidine scaffold with apoptotic activity. J Enzyme Inhib Med Chem 37(1):1957–1973
Acknowledgments
H. A. Nagaty immensely grateful to Vodafone Egypt for providing him with the invaluable opportunity to learn statistical analysis during his tenure with the company. Their commitment to employee development and continuous learning has been instrumental in expanding his knowledge and skills in statistics and their application in real-world scenarios.
Funding
This research received no external funding.
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB).
Author information
Authors and Affiliations
Contributions
R. A. El-Shiekh, M. M. Okba, R. M.S. Ashour: conceptualization, writing - original draft, data curation; formal analysis; funding acquisition, investigation, resources; methodology, review, and editing. A. A. Mandour, O. Kutkat, R. Elshimy: writing - original draft, data curation; formal analysis; funding acquisition, investigation, resources; methodology, review, and editing. H. A. Nagaty: data curation; formal analysis; methodology.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
El-Shiekh, R.A., Okba, M.M., Mandour, A.A. et al. Eucalyptus Oils Phytochemical Composition in Correlation with Their Newly Explored Anti-SARS-CoV-2 Potential: in Vitro and in Silico Approaches. Plant Foods Hum Nutr 79, 410–416 (2024). https://doi.org/10.1007/s11130-024-01159-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11130-024-01159-w